Bassel Nazha

1.7k total citations
70 papers, 1.1k citations indexed

About

Bassel Nazha is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Bassel Nazha has authored 70 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 26 papers in Surgery. Recurrent topics in Bassel Nazha's work include Renal cell carcinoma treatment (21 papers), Cancer Immunotherapy and Biomarkers (19 papers) and Bladder and Urothelial Cancer Treatments (14 papers). Bassel Nazha is often cited by papers focused on Renal cell carcinoma treatment (21 papers), Cancer Immunotherapy and Biomarkers (19 papers) and Bladder and Urothelial Cancer Treatments (14 papers). Bassel Nazha collaborates with scholars based in United States, Lebanon and Taiwan. Bassel Nazha's co-authors include Taofeek K. Owonikoko, Manoj K. Mishra, Rebecca D. Pentz, Ömer Küçük, Mehmet Asım Bilen, Jacqueline T. Brown, Bradley Curtis Carthon, James Chih‐Hsin Yang, Viraj A. Master and Sarah Caulfield and has published in prestigious journals such as Circulation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Bassel Nazha

59 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bassel Nazha United States 16 540 235 163 154 143 70 1.1k
Anneke M. Westermann Netherlands 24 436 0.8× 318 1.4× 183 1.1× 336 2.2× 103 0.7× 77 1.5k
Jesus Vera Aguilera United States 8 845 1.6× 282 1.2× 97 0.6× 164 1.1× 101 0.7× 17 1.3k
Michael Eichbaum Germany 19 355 0.7× 231 1.0× 163 1.0× 176 1.1× 107 0.7× 61 965
Manju Sengar India 19 527 1.0× 163 0.7× 157 1.0× 132 0.9× 72 0.5× 169 1.3k
Heath B. Mackley United States 21 538 1.0× 298 1.3× 199 1.2× 108 0.7× 94 0.7× 59 1.1k
Bhanu Prasad Venkatesulu United States 16 535 1.0× 372 1.6× 170 1.0× 111 0.7× 113 0.8× 53 1.2k
David Watkins United Kingdom 22 747 1.4× 446 1.9× 289 1.8× 322 2.1× 254 1.8× 81 1.4k
Valentina I. Petkov United States 16 442 0.8× 336 1.4× 203 1.2× 196 1.3× 308 2.2× 43 1.4k
Sarah M. Bean United States 20 276 0.5× 134 0.6× 287 1.8× 190 1.2× 132 0.9× 47 1.4k
Jonas Paludo United States 16 611 1.1× 139 0.6× 58 0.4× 127 0.8× 56 0.4× 150 1.2k

Countries citing papers authored by Bassel Nazha

Since Specialization
Citations

This map shows the geographic impact of Bassel Nazha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bassel Nazha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bassel Nazha more than expected).

Fields of papers citing papers by Bassel Nazha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bassel Nazha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bassel Nazha. The network helps show where Bassel Nazha may publish in the future.

Co-authorship network of co-authors of Bassel Nazha

This figure shows the co-authorship network connecting the top 25 collaborators of Bassel Nazha. A scholar is included among the top collaborators of Bassel Nazha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bassel Nazha. Bassel Nazha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Yuan, Dylan J. Martini, Wayne Harris, et al.. (2025). Non-clear cell renal cell carcinoma in the immune checkpoint era: A retrospective study on survival and treatment approaches.. Journal of Clinical Oncology. 43(5_suppl). 512–512. 1 indexed citations
3.
Master, Viraj A., et al.. (2024). Adrenocortical Carcinomas: Molecular Pathogenesis, Treatment Options, and Emerging Immunotherapy and Targeted Therapy Approaches. The Oncologist. 29(9). 738–746. 7 indexed citations
4.
Martini, Dylan J., Samuel Bidot, Bassel Nazha, et al.. (2024). Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes. American Journal of Clinical Pathology. 163(4). 618–628. 2 indexed citations
5.
Nazha, Bassel, Jacqueline T. Brown, Yu Liu, et al.. (2024). Enfortumab vedotin plus pembrolizumab in the treatment of locally advanced or metastatic bladder cancer of variant histology: A phase II study.. Journal of Clinical Oncology. 42(16_suppl). TPS4615–TPS4615. 1 indexed citations
6.
Martini, Dylan J., Kathryn L. Pellegrini, Elizabeth Beagle, et al.. (2024). PD‐L1 and nectin‐4 expression and genomic characterization of bladder cancer with divergent differentiation. Cancer. 130(21). 3658–3670. 4 indexed citations
7.
Patil, Dattatraya, Shreyas Joshi, Vikram M. Narayan, et al.. (2024). Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy. Clinical Genitourinary Cancer. 22(3). 102056–102056.
8.
Vaishampayan, Ulka N., Deepak Kilari, Tanya B. Dorff, et al.. (2024). 1600P Phase II trial of pembrolizumab and lenvatinib in advanced neuroendocrine prostate cancer (NEPC). Annals of Oncology. 35. S965–S965.
9.
Nazha, Bassel, Sharon Wu, Jacqueline T. Brown, et al.. (2023). Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune‐checkpoint inhibitor‐related biomarkers. Cancer. 129(24). 3884–3893. 21 indexed citations
10.
Elliott, Andrew, Jacqueline T. Brown, Bassel Nazha, et al.. (2023). The Genomic Landscape of Urothelial Carcinoma with High and Low ERBB2 Expression. Cancers. 15(24). 5721–5721. 5 indexed citations
11.
Martini, Dylan J., Subir Goyal, Yuan Liu, et al.. (2022). Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience. SHILAP Revista de lepidopterología. 5(3). 52–57. 1 indexed citations
12.
Ozkaya‐Ahmadov, Tevhide, Ruxiu Liu, Dohwan Lee, et al.. (2022). High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells. Nature Communications. 13(1). 3385–3385. 56 indexed citations
13.
Smith, Katherine E., Jacqueline T. Brown, Sarah Caulfield, et al.. (2022). Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer. Urologic Oncology Seminars and Original Investigations. 40(6). 271.e9–271.e18. 13 indexed citations
14.
Martini, Dylan J., Subir Goyal, Yuan Liu, et al.. (2021). Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade. Frontiers in Oncology. 11. 701345–701345. 7 indexed citations
15.
Martini, Dylan J., Subir Goyal, Yuan Liu, et al.. (2021). Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors. Frontiers in Oncology. 11. 707050–707050. 26 indexed citations
16.
Nazha, Bassel, et al.. (2016). Anaplastic lymphoma kinase inhibitors in elderly patients with advanced non-small cell lung cancer. Expert Review of Anticancer Therapy. 16(8). 877–883.
17.
Nazha, Bassel, et al.. (2015). Students’ Perceptions of Peer-Organized Extra-Curricular Research Course during Medical School: A Qualitative Study. PLoS ONE. 10(3). e0119375–e0119375. 19 indexed citations
18.
Nazha, Bassel. (2015). Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate?. World Journal of Gastrointestinal Surgery. 7(12). 370–370. 141 indexed citations
19.
Nazha, Bassel, et al.. (2015). Epidermal growth factor receptor tyrosine kinase inhibitors in elderly patients with non-small cell lung cancer. Expert Review of Anticancer Therapy. 15(11). 1327–1336. 8 indexed citations
20.
Nazha, Bassel, et al.. (2013). Aberrant Nuclear Repressor Coreceptor 1 Localization in Human Retinoblastoma. Ophthalmic Research. 49(4). 171–176. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anneke M. Westermann Breakdown of academic impact, for papers by Jesus Vera Aguilera Breakdown of academic impact, for papers by Michael Eichbaum Breakdown of academic impact, for papers by Manju Sengar Breakdown of academic impact, for papers by Heath B. Mackley Breakdown of academic impact, for papers by Bhanu Prasad Venkatesulu Breakdown of academic impact, for papers by David Watkins Breakdown of academic impact, for papers by Valentina I. Petkov Breakdown of academic impact, for papers by Sarah M. Bean Breakdown of academic impact, for papers by Jonas Paludo
Rankless by CCL
2026